Combines Ectoin's cellular water-shield protection with Ceramides' structural lipid-mortar barrier repair, providing comprehensive moisture retention and barrier restoration for atopic or damaged skin.
엑토인 · 전성분 · Living ingredient passport
Ectoin
A powerful extremophilic osmoprotectant (extremolyte) produced by halophilic bacteria that forms a protective, hydro-stabilizing water shield around cellular membranes and proteins, clinically proven to soothe inflammation, repair the skin barrier, and protect against environmental photoaging.
GentlenessGentle — four of fiveEvidenceIndicativeTopical
- INCI
- ECTOIN
Also called Ectoine · (S)-2-Methyl-1,4,5,6-tetrahydropyrimidine-4-carboxylic Acid · Tetrahydropyrimidine Derivative
The short answer
Four lines, each compressed from the section it links to. Every line carries the sources of the claim it compresses.
- What it does
Atopic Dermatitis Relief and Skin Barrier Repair
See the evidence - Where it goes
moisturizer or serum step · day and night
See how to use it - What shows, and when
one week: Significant reduction in redness, transepidermal water loss, and localized SCORAD scores in compromised or atopic skin barriers.
Source2
See the timeline
How to use it
Where it sits in the seven-step ladder, and the record's own fields for the habit.
아침DayDay: used
저녁NightNight: used
day and night
Cleanser클렌저
Toner토너
Essence에센스
Serum세럼 sits here
Eye cream아이크림
Moisturizer크림 sits here
Sunscreen자외선차단제
Filled steps are where Ectoin commonly appears. No product is recommended.
Everything here comes from the sources below. None of it is a product recommendation.
- Time of day
- day and night
- Where it sits
- moisturizer or serum step
- Starting frequency
- daily
- Amount
- pea-sized amount or few drops
- Application
- Apply evenly to clean, dry skin on the face, neck, and chest as a serum, lotion, or cream. Gently pat to encourage absorption. Safe to apply directly to raw, inflamed, or post-laser treated skin barriers.
- Storage
- Store in a cool, dry place away from direct heat and moisture. Keep container tightly closed.
Plays well with / keep apart
One card per pair. Where the partner has its own passport, the name links to it.
Do layer it with
Ectoin significantly mitigates retinoid-induced skin irritation, redness, and dryness (retinoid dermatitis) without interfering with retinoid anti-aging or cell-turnover efficacy.
Read the passportSource1
What to expect, and when
The record's own timeline. Each step keeps the source of the study it came from.
- Immediate
Instant soothing of skin tightness, itching, and dryness, establishing a protective hydro-complex moisture shield.
- one week
Significant reduction in redness, transepidermal water loss, and localized SCORAD scores in compromised or atopic skin barriers.
Source2
- four weeks
Noticeable improvement in skin elasticity, fine line depth, and overall barrier resilience, with reduced need for topical corticosteroid rescue therapy in inflammatory skin conditions.
Is this safe for me
Everything the record says about suitability, consolidated. Pause-first comes first.
Before you start
Hypoallergenic and exceptionally safe for all skin types, including infants and raw, reactive, or eczema-prone skin barriers.
Good match for
Exhibits an outstanding safety and tolerability profile across infants, children, and adults, with zero known skin sensitization or irritation potential even on raw or compromised skin barriers.
Best match
damaged skin barrier
atopic-prone skin · sensitive skin · dehydrated skin · aging skin · environmentally stressed skin
Routine
moisturizer or serum step
Pregnancy and breastfeeding
Not medical advice · ask your own clinician
Pregnancy. A 2011 dermatology review of skin-care product safety in pregnancy names hydroquinone (high systemic absorption) and tretinoin (evidence controversial) as the actives of concern, and states that most other topical skin-care products act locally and produce minimal systemic absorption; Ectoin is not named among the flagged concerns 6. This is general topical-product reasoning rather than an ingredient-specific safety trial. If you are pregnant, ask your doctor before use.
Breastfeeding. Topical application is applied locally with minimal expected systemic absorption; no ingredient-specific breastfeeding safety trial was located. As a general precaution common to topical actives, avoid applying directly to the breast or nipple area, since incidental transfer to a nursing infant has not been studied for this ingredient. If you are breastfeeding, ask your doctor before use.
| Common, and it usually settles | Stop using it |
|---|---|
| None typically expected. Ectoin is extraordinarily well tolerated and hypoallergenic, even on infants and compromised skin. | persistent redness |
| localized itching | |
| burning sensation | |
| allergic hives |
Allergen history
A dedicated search of the peer-reviewed literature (PubMed) for ectoin and ectoine allergic contact dermatitis, contact allergy, hypersensitivity, adverse reaction, and sensitization case reports found none. This is consistent with the ingredient's own clinical trial record: the flagship atopic dermatitis sources report the ectoin-containing cream EHK02-01 as very well tolerated with no reported adverse events across pediatric and adult populations 1,2, and the vehicle-controlled anti-aging trial reported zero side effects among its healthy volunteer cohort 3.
Who should not use it
A dedicated search of the peer-reviewed literature did not locate any documented contraindication for ectoin specific to topical cosmetic use.
What it will not do
- The high-efficacy SCORAD reduction and atopic dermatitis resolution demonstrated with 5.5%-7.0% medical ectoin creams cannot be directly assumed for low-dose (0.1%-0.5%) rinse-off cleansers due to minimal contact time.
- The cellular membrane protection and protein stabilization provided by topical Ectoin Hydro-Complex cannot replace broad-spectrum UV filters (sunscreens), as Ectoin absorbs UV indirectly through cellular protection rather than functioning as an active chemical filter.
- The rapid barrier-rebuilding results achieved with bio-fermented pure Ectoin cannot be assumed for unpurified bacterial lysate crude mixtures containing endotoxins or salt residues.
The evidence
One card per claim. Concentration, form, population and limitation sit with it, always visible.
Grade legend
- Indicative
- Limited
- Moderate
- Strong
Atopic Dermatitis Relief and Skin Barrier Repair
IndicativeReduces skin dryness, pruritus (itching), and local SCORAD atopic dermatitis severity scores while rebuilding damaged epidermal barrier function.1,2
- Tested concentration
- 5.5% to 7.0%
- Which form
- Pure Bio-Fermented Ectoin
- Population and duration
- 65 patients aged 18-65 with mild to moderate atopic dermatitis applying 5.5-7.0% ectoin cream vs nonsteroidal comparator cream twice daily for 28 days, backed by a systematic review of 230 references across pediatric and adult cohorts
- Limitation
- Tested in clinical atopic dermatitis formulations at 5.5-7.0% concentrations; lower cosmetic maintenance doses (0.5-2.0%) provide daily hydration and barrier protection rather than acute medical eczema resolution.
Anti-Aging, Skin Hydration, and Surface Structure Improvement
IndicativeSignificantly improves skin hydration, elasticity, and surface smooth structure while protecting against photoaging and collagen degradation.3
- Tested concentration
- 2.0%
- Which form
- Pure Bio-Fermented Ectoin
- Population and duration
- 104 healthy female volunteers applying 2% Ectoin emulsion vs vehicle control on split face/forearms for 4 weeks
- Limitation
- Consistent daily application is required to maintain the Ectoin Hydro-Complex water shield and prevent transepidermal water loss.
Mitigation of Retinoid Dermatitis and Barrier Stress
IndicativeReduces retinoid-induced skin dryness, erythema, and scaling in patients undergoing retinoid therapy.1
- Tested concentration
- 5.0% to 7.0%
- Which form
- Pure Bio-Fermented Ectoin
- Population and duration
- Patients undergoing isotretinoin or topical retinoid therapy, drawn from the systematic review's included retinoid-dermatitis study, over a four-week course
- Limitation
- Serves as a supportive, soothing barrier adjuvant rather than a replacement for primary acne medication.
Open
How we verify Large-scale, multi-center, double-blind, randomized controlled human trials evaluating pure 1.0% Ectoin as a standalone leave-on monotherapy (without other active emollients or cica extracts) for long-term facial skin barrier recovery and wrinkle depth reduction over 12 weeks.
Questions & related
Common questions · 자주 묻는 질문
What is Ectoin and how does it differ from Hyaluronic Acid?
Ectoin is an extremolyte—a cyclic amino acid derivative produced by extremophilic bacteria to survive severe drought, heat, and high salinity. While Hyaluronic Acid functions primarily as a surface and epidermal water-binding humectant, Ectoin forms a physical 'Hydro-Complex' shell around cell membranes and proteins, actively protecting cells from environmental stress, UV damage, and inflammatory breakdown while strengthening tight junctions.
Is Ectoin safe for babies and eczema-prone skin?
Yes. Ectoin has an exceptional dermatological safety profile and is clinically proven in pediatric clinical trials to be well tolerated by infants and children 1. Formulations containing 5.5% to 7.0% Ectoin are widely used in Europe and South Korea as medical device creams and daily emollients for atopic dermatitis and eczema.
The clinical recordHow it works · Forms · Manufacturing · Regulations · Study ledger · Gaps · Sources
How it works
Ectoin is a zwitterionic cyclic amino acid derivative that acts as a powerful osmoprotectant. It tightly binds surrounding water molecules to form the 'Ectoin Hydro-Complex', a stable, protective hydration shell around proteins and cell membranes 4. This physical water shield stabilizes lipid bilayers, prevents stress-induced protein denaturation, suppresses inflammatory cytokine signaling (IL-1 alpha, IL-6, TNF-alpha), and upregulates tight junction proteins (loricrin, involucrin) 5.
- Formation of the Ectoin Hydro-Complex
Tightly structures water molecules around cell membranes and proteins, creating a protective physical water shell that prevents cell shrinkage, lipid bilayer fluidization, and stress-induced protein denaturation.
What that rests on: biophysical and molecular models
Source4
- Up-regulation of Tight Junctions and Cornified Envelope Genes
Increases the gene and protein expression of loricrin (LOR), involucrin (INV), and tight junction proteins, restoring epidermal physical barrier integrity under cortisone or environmental stress.
What that rests on: in-vitro human keratinocyte assays
Source5
- Inhibition of Stress-Induced MMP-1 and Inflammatory Cytokines
Inhibits UVA/UVB-stimulated activator protein-1 (AP-1) and NF-kB signaling pathways, suppressing MMP-1 collagen degradation and inflammatory cytokine release.
What that rests on: in-vitro human fibroblast and keratinocyte models
Source4
Reading the label
- Find this name
- 엑토인 (Ectoin) — a natural extremolyte osmoprotectant that forms a protective water shield around cellular structures.
- Terms that may mislead
- It is not on the MFDS publicly notified (고시형) list of functional anti-wrinkle or whitening actives, so K-beauty brands co-dose it with Adenosine 0.04% or Niacinamide 2-5% for simplified functional cosmetic registration.
- Judge production transparency
- Manufacturers disclose HPLC purity assays, moisture content, endotoxin levels, heavy metals, and microbiological testing. Specific nutrient media formulations and proprietary fermentation vessel parameters are kept as trade secrets.
| Attribute | Pure Bio-Fermented Ectoin |
|---|---|
| What it is | The highly pure, crystalline, natural cyclic amino acid derivative that binds water molecules to form the Ectoin Hydro-Complex around cell membranes. |
| Official INCI | ECTOIN |
| Where it comes from | Bacterial fermentation of halophilic microorganisms (such as Halomonas elongata) |
| How it is made | Produced via sustainable industrial bacterial fermentation of extremophilic Halomonas elongata in high-salinity media, followed by cell separation, microfiltration, crystallization, and high-purity purification. |
| Gentleness | Exceptionally gentle, hypoallergenic, and non-sensitizing across pediatric and adult sensitive skin cohorts. |
How it is actually made
- Origin regions: Germany, South Korea, China, Spain
- Produced industrially via modern biotechnology through the controlled bacterial fermentation of halophilic micro-organisms (primarily Halomonas elongata) in high-salinity culture media. The bacterial cells synthesize and accumulate ectoin intracellularly to survive osmotic stress ('bacterial milking'), followed by microfiltration, membrane separation, crystallization, and high-purity purification.
- Potency is controlled by standardizing Ectoin assay purity to a minimum of 99.0% using High-Performance Liquid Chromatography (HPLC), with strict endotoxin testing (<= 0.05 EU/mg) to ensure pediatric and medical-grade safety.
- Biotechnological fermentation provides a highly sustainable, eco-friendly, and non-animal supply chain independent of wild harvesting.
- Manufacturers disclose HPLC purity assays, moisture content, endotoxin levels, heavy metals, and microbiological testing. Specific nutrient media formulations and proprietary fermentation vessel parameters are kept as trade secrets.
Where the ceiling is set
European Union
In force since 2013-07-11- The rule
- EU Cosmetics Regulation (EC) No 1223/2009
- What it allows
- Approved for cosmetic use with no concentration restrictions. Listed in the CosIng database under ECTOIN as a skin conditioning and protecting agent.
South Korea
In force since 2012-02-05- The rule
- Ministry of Food and Drug Safety (MFDS) Cosmetics Safety Standards
- What it allows
- Approved as a safe, general cosmetic raw material. It is not on the MFDS publicly notified (고시형) list of functional anti-wrinkle or whitening actives, so K-beauty brands co-dose it with Adenosine 0.04% or Niacinamide 2-5% for simplified functional cosmetic registration.
What the evidence rests on
Study records
Systematic literature review of 6 clinical trials (n=230 references screened)2022
Topical Ectoine Application in Children and Adults to Treat Inflammatory Diseases Associated with an Impaired Skin Barrier: A Systematic Review
Topical 5.5-7.0% ectoin formulations significantly reduced skin dryness, pruritus, and SCORAD scores in atopic dermatitis across infants, children, and adults with excellent 4-week tolerability. In adjuvant settings, ectoin reduced the need for topical corticosteroids and effectively mitigated retinoid dermatitis.
Where it falls shortSynthesizes data across diverse clinical trial designs and pediatric/adult populations.
Source1
Randomized, intra-individual, double-blind, multi-center clinical trial2013
Ectoine-containing cream in the treatment of mild to moderate atopic dermatitis: a randomised, comparator-controlled, intra-individual double-blind, multi-center trial
Twice-daily application of EHK02-01 ectoin cream for 28 days in 65 patients with mild to moderate atopic dermatitis significantly reduced local SCORAD and IGA scores, demonstrating equivalent therapeutic efficacy to the reference anti-inflammatory cream with excellent tolerability.
Where it falls shortEvaluated on mild to moderate symmetrical atopic lesions over 28 days; severe atopic flare-ups require medical supervision.
Source2
Monocentric, randomized, double-blind application trial2007
In vivo assessment of Ectoin: a randomized, vehicle-controlled clinical trial
Topical application of 2% Ectoin formulation over 4 weeks in 104 healthy female volunteers led to statistically significant improvements in skin hydration, skin surface smooth structure, and elasticity compared to vehicle control with zero side effects.
Where it falls shortEvaluated at 2% concentration in healthy female subjects; higher concentrations may be required for acute medical inflammatory conditions.
Source3
Systematic scientific and biotechnological review2025
Ectoine as a multifunctional molecule: biotechnological production and pharmaceutical applications
Comprehensive review detailing Ectoin's ability to bind water molecules into the Ectoin Hydro-Complex, stabilizing cell membranes, protecting proteins against thermal and UV denaturation, and inhibiting MMP-1 collagen breakdown.
Where it falls shortSummarizes mechanistic and preclinical data across multiple formulation types.
Source4
In-vitro cellular and molecular gene expression assay2024
Ectoin attenuates cortisone-induced skin issues by suppression GR signaling and the UVB-induced overexpression of 11b-HSD1
Ectoin treatment significantly restored cornified envelope formation and tight junction integrity by upregulating loricrin (LOR) and involucrin (INV) expression under cortisone and stress conditions.
Where it falls shortIn-vitro human keratinocyte cell culture model; clinical in-vivo correlation required.
Source5
What is still missing
Large-scale, multi-center, double-blind, randomized controlled human trials evaluating pure 1.0% Ectoin as a standalone leave-on monotherapy (without other active emollients or cica extracts) for long-term facial skin barrier recovery and wrinkle depth reduction over 12 weeks.
The precise independent anti-wrinkle and long-term barrier-reinforcing efficacy of low-dose (1%) cosmetic Ectoin monotherapy remains a clinical estimation, as existing human trials focus heavily on 2% anti-aging or 5.5-7.0% medical eczema creams.
NeedsA randomized, double-blind, vehicle-controlled clinical trial assessing 1% pure Ectoin cream vs vehicle base cream on 100 sensitive-skin subjects over 12 weeks.
Sources on file
- Kauth M, Trusova OV. Topical Ectoine Application in Children and Adults to Treat Inflammatory Diseases Associated with an Impaired Skin Barrier: A Systematic Review. Dermatol Ther (Heidelb) (2022)(opens in a new tab)
- Marini A, Reinelt K, Krutmann J, Bilstein A. Ectoine-containing cream in the treatment of mild to moderate atopic dermatitis. Skin Pharmacol Physiol (2013)(opens in a new tab)
- Heinrich U, Garbe B, Tronnier H. In vivo assessment of Ectoin: a randomized, vehicle-controlled clinical trial. Skin Pharmacol Physiol (2007)(opens in a new tab)
- Ferreira P, et al. Ectoine as a multifunctional molecule: biotechnological production and pharmaceutical applications. Drug Deliv Transl Res (2025)(opens in a new tab)
- Xu D, Wu Y. Ectoin attenuates cortisone-induced skin issues by suppression GR signaling and the UVB-induced overexpression of 11beta-HSD1. J Cosmet Dermatol (2024)(opens in a new tab)
- Bozzo, Chua-Gocheco & Einarson. Can Fam Physician (2011)(opens in a new tab)